{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-10-30T12:23:12.957374+00:00",
  "news": [
    {
      "title": "Earnings Preview: Amgen (AMGN) Q3 Earnings Expected to Decline - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxNWXVyRHlaNENCWWZWUkR2QXlMTG1iRmpubENaTU0zeTY1VVBwMnNwY1l5UGJxZDhyQk9rZlIzRlVCLWxOSkd3UkNuMnBseXRPMC1IeGpjanNWWHdjbDlOUFdON3lEcnRUN0VzNWl1WkY3aGhwVF9pdkFXb0E1MVVxb0hn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxNWXVyRHlaNENCWWZWUkR2QXlMTG1iRmpubENaTU0zeTY1VVBwMnNwY1l5UGJxZDhyQk9rZlIzRlVCLWxOSkd3UkNuMnBseXRPMC1IeGpjanNWWHdjbDlOUFdON3lEcnRUN0VzNWl1WkY3aGhwVF9pdkFXb0E1MVVxb0hn?oc=5\" target=\"_blank\">Earnings Preview: Amgen (AMGN) Q3 Earnings Expected to Decline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-28T14:00:07+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Evaluating Amgen (AMGN): Is Current Valuation Attractive After Recent 1-Month Momentum? - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Evaluating Amgen (AMGN): Is Current Valuation Attractive After Recent 1-Month Momentum?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-10-30T05:39:26+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Econ Financial Services Corp Acquires New Position in Amgen Inc. $AMGN - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxONXFoX29YUmd0bjZNQ3Y0ZzJIazlVZTZqUmthTXBUWWotckJXT0ZlcmVZY0drRXljYkRSd2MwTEpsSkdTNDN4cHo5Z3RiRkhocS1STWZnd3NobS12N05HRUFGRmNnWG1EaWNkSzAzOVBGNFU5RkFUYVVTMERyN0tmaHduUmd1NFhHT2htdWZIWVJDRFV3dTdIQ0RKM3dEbEI0aml6eHp0N1lEd09oRXM2QWt0NWpvSUl0Skp2RW1ObFNCZWU4UjBFTA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiyAFBVV95cUxONXFoX29YUmd0bjZNQ3Y0ZzJIazlVZTZqUmthTXBUWWotckJXT0ZlcmVZY0drRXljYkRSd2MwTEpsSkdTNDN4cHo5Z3RiRkhocS1STWZnd3NobS12N05HRUFGRmNnWG1EaWNkSzAzOVBGNFU5RkFUYVVTMERyN0tmaHduUmd1NFhHT2htdWZIWVJDRFV3dTdIQ0RKM3dEbEI0aml6eHp0N1lEd09oRXM2QWt0NWpvSUl0Skp2RW1ObFNCZWU4UjBFTA?oc=5\" target=\"_blank\">Econ Financial Services Corp Acquires New Position in Amgen Inc. $AMGN</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-10-30T11:10:19+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "AMGEN ANNOUNCES WEBCAST OF 2025 THIRD QUARTER FINANCIAL RESULTS - Stock Titan",
      "link": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPRDdBMklLYmRQVDNMRVE5aVFLdV9tdHBhaGJNemZaX0I1VE9zOU9nRFBCTWhIelNCNU9zZEtqN3lKYndWNVYwNXB0XzNUaU5La1RINmtacmNRR1N1NXo3dG1hdUFvaktEZUhMWmhPTGR1RmhCOEoySDdoQ1JIMG9neFZlSnhFa1lfeUwtYWlxblQ2YmJFVnZsVVdfa3FsOWY2UnlzZmpYS2trNGFWSWZr?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMirwFBVV95cUxPRDdBMklLYmRQVDNMRVE5aVFLdV9tdHBhaGJNemZaX0I1VE9zOU9nRFBCTWhIelNCNU9zZEtqN3lKYndWNVYwNXB0XzNUaU5La1RINmtacmNRR1N1NXo3dG1hdUFvaktEZUhMWmhPTGR1RmhCOEoySDdoQ1JIMG9neFZlSnhFa1lfeUwtYWlxblQ2YmJFVnZsVVdfa3FsOWY2UnlzZmpYS2trNGFWSWZr?oc=5\" target=\"_blank\">AMGEN ANNOUNCES WEBCAST OF 2025 THIRD QUARTER FINANCIAL RESULTS</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Stock Titan</font>",
      "published": "2025-10-29T20:01:00+00:00",
      "source": "Stock Titan"
    },
    {
      "title": "Amgen Stock (AMGN) Opinions on Recent Price Dip and Drug Approvals - Quiver Quantitative",
      "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQZ21LbldYR0xBRzZuZE4zSW5XMDJoZFI3eXVPQjhKOHI3N1cxNi1PTHhpU2h5bVU3cVJPLWxhVzlZRGR4RE81YWoxcm1nZVVZVlJlTW82Zi1UeDYwZFNpS05vanFjWDFyOTNFQ0ZlS2x0Ui1ZUDV6cElwNzk4aGN2NEI0d0F2UVlfYjZMWGtoaXdyV0cteV80akpCVFNmNmZPcGh6cmh3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipgFBVV95cUxQZ21LbldYR0xBRzZuZE4zSW5XMDJoZFI3eXVPQjhKOHI3N1cxNi1PTHhpU2h5bVU3cVJPLWxhVzlZRGR4RE81YWoxcm1nZVVZVlJlTW82Zi1UeDYwZFNpS05vanFjWDFyOTNFQ0ZlS2x0Ui1ZUDV6cElwNzk4aGN2NEI0d0F2UVlfYjZMWGtoaXdyV0cteV80akpCVFNmNmZPcGh6cmh3?oc=5\" target=\"_blank\">Amgen Stock (AMGN) Opinions on Recent Price Dip and Drug Approvals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Quiver Quantitative</font>",
      "published": "2025-10-29T14:06:00+00:00",
      "source": "Quiver Quantitative"
    },
    {
      "title": "Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices - The New York Times",
      "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPOGtMT0RzU0RhVGtHcjRGc1ZveDNZOUJLMGh3eVB2S3Eyb21tSUpmczRHUEtmWUYtdnlXVGNFUHN6RUVNa3BtZGNGcG1zVEJaZEZUdi03R2R4VHVENzBxcjhrektwRTNFOWpOSTZuSzFpbkRWZktQeDROQkdiV0RCcnBpRFljTDRXSkhWbklkZFhNLW8?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikwFBVV95cUxPOGtMT0RzU0RhVGtHcjRGc1ZveDNZOUJLMGh3eVB2S3Eyb21tSUpmczRHUEtmWUYtdnlXVGNFUHN6RUVNa3BtZGNGcG1zVEJaZEZUdi03R2R4VHVENzBxcjhrektwRTNFOWpOSTZuSzFpbkRWZktQeDROQkdiV0RCcnBpRFljTDRXSkhWbklkZFhNLW8?oc=5\" target=\"_blank\">Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The New York Times</font>",
      "published": "2025-10-23T09:00:45+00:00",
      "source": "The New York Times"
    },
    {
      "title": "US FDA expands use of Amgen, AstraZeneca's drug for chronic inflammatory sinus disease - Reuters",
      "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPdHIxQV8zM2pKOENLQm1ULVdWcXd6b2wzYzhxd3p2aHE5ZTd5RWs0UWx6QTd1VDJ1RXpkbUVUWG1JT3UzSmZrVER6OUVMNFNSZXFGa2FWdmpaVWxsVVl3VFNhS1hydC1YaDgwTDdob3l1dFBFaU9PZTVwUXpsM3AteGZ2ZjhFd2FJYWlfbzFWcUxacFFPOU9rQUNNWXprUUZmTTQwRHpzcjRRZTV0ZEQ3QWdRMkpYNW9GUDlwcnY4d3ROTEE0bS1tZldB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiygFBVV95cUxPdHIxQV8zM2pKOENLQm1ULVdWcXd6b2wzYzhxd3p2aHE5ZTd5RWs0UWx6QTd1VDJ1RXpkbUVUWG1JT3UzSmZrVER6OUVMNFNSZXFGa2FWdmpaVWxsVVl3VFNhS1hydC1YaDgwTDdob3l1dFBFaU9PZTVwUXpsM3AteGZ2ZjhFd2FJYWlfbzFWcUxacFFPOU9rQUNNWXprUUZmTTQwRHpzcjRRZTV0ZEQ3QWdRMkpYNW9GUDlwcnY4d3ROTEE0bS1tZldB?oc=5\" target=\"_blank\">US FDA expands use of Amgen, AstraZeneca's drug for chronic inflammatory sinus disease</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-10-17T07:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxOVC03UXRKQ3Q4OTFzYjh5bUV6WWRRRHVOU2pqcDY1MGhUbm1PQnZCTEpQYzZhcFlsN2pDSHZTU0xib0JuVVhuTlBMMVVuRGhtX1F0clBxVHM2Z2lUR1VRSkItM3VvVGh6R0NPMWhaTkRZRGVOVlFhNzdGUkZ5UWpzRk4zU2xIdkdRMkFrRl83UjB2LXFjMWdRUXh1aUs3WG94SXI5NWJqVVEyYzFSZVY5TERfZGlJOC1DbVM4RnNBbFJOVW9GbW9PQ1NydXBsdHdtTkE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOVC03UXRKQ3Q4OTFzYjh5bUV6WWRRRHVOU2pqcDY1MGhUbm1PQnZCTEpQYzZhcFlsN2pDSHZTU0xib0JuVVhuTlBMMVVuRGhtX1F0clBxVHM2Z2lUR1VRSkItM3VvVGh6R0NPMWhaTkRZRGVOVlFhNzdGUkZ5UWpzRk4zU2xIdkdRMkFrRl83UjB2LXFjMWdRUXh1aUs3WG94SXI5NWJqVVEyYzFSZVY5TERfZGlJOC1DbVM4RnNBbFJOVW9GbW9PQ1NydXBsdHdtTkE?oc=5\" target=\"_blank\">AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2025-09-26T07:00:00+00:00",
      "source": "PR Newswire"
    }
  ],
  "product_launches": [
    {
      "title": "Endo Launches First Generic Version of Amgen’s RAVICTI, Expanding Access for Rare Disease Patients - MyChesCo",
      "link": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxNejJnZmFlNXA2dGd5ZDhMY3JHY25lNW9CNmV2SHkzVThEZ2YtbUp0RHVXYmVRUjUyNzFLc0RicXdCQkl5blVxRWNCbzdxWEFMQ3lHNWlocFc2SFNUcC1hNHZSOGF4aVhJaEtQNzYzMTR2QWxtMXFMMlFGcnV2N0VHNDAzQVFHMUNyTjJuTE5BOEZjdWlZdFMzc2hoUVBPZkRUQnBzUWp4MUk4WFFDRlJQZl9JeEtKbzFHRFl2ZER6WEVMa1E2eFV3RmhtTzZhMUVXdXRBdGpxdThYQklWWHFDTF9rSXNObVo4d0tlbw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNejJnZmFlNXA2dGd5ZDhMY3JHY25lNW9CNmV2SHkzVThEZ2YtbUp0RHVXYmVRUjUyNzFLc0RicXdCQkl5blVxRWNCbzdxWEFMQ3lHNWlocFc2SFNUcC1hNHZSOGF4aVhJaEtQNzYzMTR2QWxtMXFMMlFGcnV2N0VHNDAzQVFHMUNyTjJuTE5BOEZjdWlZdFMzc2hoUVBPZkRUQnBzUWp4MUk4WFFDRlJQZl9JeEtKbzFHRFl2ZER6WEVMa1E2eFV3RmhtTzZhMUVXdXRBdGpxdThYQklWWHFDTF9rSXNObVo4d0tlbw?oc=5\" target=\"_blank\">Endo Launches First Generic Version of Amgen’s RAVICTI, Expanding Access for Rare Disease Patients</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MyChesCo</font>",
      "published": "2025-10-27T04:00:00+00:00",
      "source": "MyChesCo"
    },
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "$239/month for Repatha — AmgenNow direct-to-patient program offers nearly 60% discount in U.S. - Stock Titan",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNX1VmYlB3RmtYTG5rd1dJblFhNVh6UEFHdzkxTm9VRy0wMVc1SDNuZ0JLYUNRTHA0VVhBOEpWb1RUa2FONTVMY19CSTJSVVJSUjFwbkIwMFdtalFEWHRmQTVvQnFzY3YxYUFqaDc2cjBydnV0RjdSWGhCTzdaWDl1Y2VNVU9LdzZvLW1FZHhnam12Qm1XaEg0M3ZEeTh4aHNkcUZsazNRa0tuTGY3WXNiZjZKSnh2SkJRVVl6OXRR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxNX1VmYlB3RmtYTG5rd1dJblFhNVh6UEFHdzkxTm9VRy0wMVc1SDNuZ0JLYUNRTHA0VVhBOEpWb1RUa2FONTVMY19CSTJSVVJSUjFwbkIwMFdtalFEWHRmQTVvQnFzY3YxYUFqaDc2cjBydnV0RjdSWGhCTzdaWDl1Y2VNVU9LdzZvLW1FZHhnam12Qm1XaEg0M3ZEeTh4aHNkcUZsazNRa0tuTGY3WXNiZjZKSnh2SkJRVVl6OXRR?oc=5\" target=\"_blank\">$239/month for Repatha — AmgenNow direct-to-patient program offers nearly 60% discount in U.S.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Stock Titan</font>",
      "published": "2025-10-06T07:00:00+00:00",
      "source": "Stock Titan"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-10-29",
      "close": 291.7699890136719
    },
    "history": [
      {
        "date": "2025-10-21",
        "close": 301.1400146484375
      },
      {
        "date": "2025-10-22",
        "close": 295.9800109863281
      },
      {
        "date": "2025-10-23",
        "close": 292.8900146484375
      },
      {
        "date": "2025-10-24",
        "close": 291.760009765625
      },
      {
        "date": "2025-10-27",
        "close": 291.1600036621094
      },
      {
        "date": "2025-10-28",
        "close": 292.0899963378906
      },
      {
        "date": "2025-10-29",
        "close": 291.7699890136719
      }
    ],
    "name": "Amgen Inc."
  }
}